Open access
4,640
Views
27
CrossRef citations to date
0
Altmetric
Original Research
In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis
Marco GalluzzoDermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;Department of “Experimental Medicine”, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-3424-5175
Simone D’AdamioDermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy
, Dionisio SilvaggioDermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy
, Paolo LombardoDermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy
, Luca BianchiDermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;Department of “Medicina dei Sistemi”, University of Rome “Tor Vergata”, Rome, Italy
& Marina TalamontiDermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;Department of “Medicina dei Sistemi”, University of Rome “Tor Vergata”, Rome, Italy
https://orcid.org/0000-0002-3070-4071
Pages 173-182
|
Received 11 Dec 2019, Accepted 20 Dec 2019, Published online: 27 Dec 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.